Primary Site >> Pancreatic Cancer

Gene >> OGFR

Journal: Int J Mol Med. 2000 Jan;5(1):77-84.
Title: Identification and characterization of opioid growth factor receptor in human pancreatic adenocarcinoma.
Author: Zagon, I S|Smith, J P|Conter, R|McLaughlin, P J
PMID: 10601579
Journal: Cancer Chemother Pharmacol. 2005 Nov;56(5):510-20.
Title: Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma.
Author: Zagon, Ian S|Jaglowski, Jeffrey R|Verderame, Michael F|Smith, Jill P|Leure-Dupree, Alphonse E|McLaughlin, Patricia J
PMID: 15947928
Journal: Int J Oncol. 2007 Apr;30(4):775-83.
Title: Overexpression of the opioid growth factor receptor potentiates growth inhibition in human pancreatic cancer cells.
Author: Zagon, Ian S|Verderame, Michael F|Hankins, Jody|McLaughlin, Patricia J
PMID: 17332915
Journal: Mol Cancer. 2008 Jan 11;7:5.
Title: The OGF-OGFr axis utilizes the p21 pathway to restrict progression of human pancreatic cancer.
Author: Cheng, Fan|McLaughlin, Patricia J|Verderame, Michael F|Zagon, Ian S
PMID: 18190706
Journal: Int J Oncol. 2008 Aug;33(2):317-23.
Title: Prevention and delay in progression of human pancreatic cancer by stable overexpression of the opioid growth factor receptor.
Author: Zagon, Ian S|Kreiner, Shawn|Heslop, Jeffery J|Conway, Andrea B|Morgan, Clinton R|McLaughlin, Patricia J
PMID: 18636152
Journal: World J Gastroenterol. 2014 Mar 7;20(9):2218-23.
Title: Opioid growth factor and the treatment of human pancreatic cancer: a review.
Author: Zagon, Ian S|McLaughlin, Patricia J
PMID: 24605021